Compare VBNK & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VBNK | VALN |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | Canada | France |
| Employees | 131 | N/A |
| Industry | Commercial Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 466.9M | 537.8M |
| IPO Year | 2016 | 2021 |
| Metric | VBNK | VALN |
|---|---|---|
| Price | $14.57 | $6.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $13.00 | ★ $15.75 |
| AVG Volume (30 Days) | 30.7K | ★ 128.2K |
| Earning Date | 03-03-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.50% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $37.90 | $4.00 |
| Revenue Next Year | $29.87 | $92.04 |
| P/E Ratio | $25.91 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.51 | $5.43 |
| 52 Week High | $17.47 | $12.25 |
| Indicator | VBNK | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 51.04 | 25.51 |
| Support Level | $13.84 | $5.69 |
| Resistance Level | $15.04 | $6.73 |
| Average True Range (ATR) | 0.39 | 0.38 |
| MACD | 0.14 | -0.33 |
| Stochastic Oscillator | 73.01 | 1.11 |
VersaBank is a Schedule I Canadian bank that provides mainly commercial lending and banking services to select niche markets in Canada and the United States. Its products and services include credit assets, deposits, and cybersecurity services through its wholly owned subsidiary. The bank operates through four segments: Digital Banking Canada and Digital Banking USA, both using a business-to-business model with proprietary financial technology to serve underserved markets; DRTC, which provides cybersecurity services and banking and financial technology development; and Digital Meteor, which owns proprietary technology supporting next-generation digital assets, including Real Bank Deposit Tokens (RBDTs). The majority of revenue comes from Digital Banking.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.